Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update & Manufacturing Footprint Review

22 Oct 2019 07:00

RNS Number : 6238Q
Devro PLC
22 October 2019
 

22 October 2019

 

Devro plc

 

Trading Update, Outlook and Global Manufacturing Footprint Review

 

Devro plc ("Devro" or the "Group"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the period 1 July to 30 September 2019 (the "period" or "Q3").

Trading Update and Outlook

Sales momentum improved during Q3 2019 with 1% volume growth in collagen casings (H1 2019: -1%). During the period we saw good trading in North America, where we benefited from continued growth in snacking categories, and also in China, due to continued strong growth albeit at margins below the average for the Group. These positive performances were offset by a further deterioration in market conditions in Continental Europe and weaker than expected sales in Japan. As anticipated, UK & Ireland and Australia saw similar trends to H1 2019.

We continue to expect a modest acceleration of volume growth in Q4 2019 with full year volume growth expected at c.1%. Our cost saving initiatives are progressing well and we are confident of achieving our guidance of £7 million in FY 2019. We continue to expect the covenant net debt / underlying EBITDA ratio to be around 2x at 31 December 2019.

Our expectations for the full year remain broadly unchanged as growth in underlying operating profit through higher volumes, delivery of costs savings and positive FX will be offset by adverse country/product mix, lower revenues from other products and energy and wage inflation which was highlighted in previous announcements.

Global Manufacturing Footprint Review

In line with our strategic priorities, the Group has undertaken a review of its global manufacturing footprint with the aim to pursue further efficiency improvements, as well as to align available capacity to the Group's growth ambitions.

As a result of this review we are proposing to close our Bellshill site in Scotland and, consequently, to increase the portfolio of products manufactured in our Moodiesburn site in Lanarkshire and relocate some of the Bellshill's manufacturing assets within the wider Group. Following consultation, we expect Bellshill to close during 2020 with the loss of c.90 employees. An exceptional cost of £15m (£10m of cash) will be incurred (2019: £11m exceptional profit and loss charge, £1m exceptional cash charge; 2020: £4m exceptional profit and loss charge, £9m exceptional cash charge). The investment associated with these actions is within our longer-term capital programme and, as such, our capital expenditure guidance for FY 2020 (£18m) remains unchanged. This review has identified annualised cost savings of £5m to be fully realised in FY 2021.

Additionally as part of the global manufacturing footprint review and the intended closure of Bellshill the Group is analysing its ongoing supply strategy. This is expected to result in non-cash exceptional impairment charges in FY 2019, primarily relating to partial write-downs of the China and US plants. These plants continue to be an integral part of our global footprint and the revised supply strategy will enhance the agility and flexibility of the Group's supply chain whilst staying focussed on our long-term growth ambitions.

ENDS

 

Contacts:

 

Devro plc

Rutger Helbing

Chief Executive Officer

Tel: 020 3865 7637

Jackie Callaway

Chief Financial Officer

Tel: 020 3865 7637

 

FTI Consulting

Richard Mountain / Nick Hasell

Tel: 020 3727 1340

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBCBDGIBDBGCB
Date   Source Headline
29th Nov 20225:23 pmRNSDirector/PDMR Shareholding
29th Nov 20225:11 pmRNSForm 8.3 - Devro Plc
29th Nov 20223:28 pmRNSForm 8.3 - Devro plc
29th Nov 20223:24 pmBUSForm 8.3 - DEVRO PLC
29th Nov 20222:34 pmRNSForm 8.3 - DEVRO PLC
29th Nov 202212:47 pmRNSForm 8.3 - Devro plc
29th Nov 202211:23 amGNWForm 8.3 - [Devro plc - 28 11 2022] - (CGWL)
29th Nov 202211:15 amRNSForm 8.3 - Devro Plc
29th Nov 20229:58 amRNSForm 8.5 (EPT/RI) - Devro PLC
29th Nov 20229:45 amRNSForm 8.5 (EPT/RI)-Devro plc
29th Nov 20228:19 amRNSForm 8.3 - Devro PLC Amendment
28th Nov 20224:36 pmRNSForm 8.3 -Devro plc - Amendment
28th Nov 20223:21 pmRNSForm 8.3 - Devro Plc
28th Nov 20223:20 pmRNSForm 8.3 - Devro plc
28th Nov 20223:14 pmRNSForm 8.3 - Devro PLC
28th Nov 20223:03 pmRNSForm 8.3 - Devro plc
28th Nov 20222:59 pmRNSForm 8.3 - Devro PLC
28th Nov 20222:27 pmRNSForm 8.3 - Devro plc
28th Nov 20222:04 pmRNSForm 8.3 - Devro Plc
28th Nov 20221:45 pmRNSForm 8.3 - Devro PLC (closing postion)
28th Nov 20221:27 pmEQSForm 8.3 - The Vanguard Group, Inc.: Devro plc
28th Nov 20221:13 pmRNSForm 8.3 - Devro plc
28th Nov 202212:50 pmRNSForm 8.3 - DEVRO PLC
28th Nov 202212:06 pmRNSForm 8.3 - Devro Plc
28th Nov 202212:01 pmRNSForm 8.3 - Devro Plc
28th Nov 202211:03 amBUSForm 8.3 - Devro plc
28th Nov 202210:51 amRNSForm 8.3 - Devro PLC
28th Nov 202210:39 amGNWForm 8.3 - [DEVRO PLC 25 11 2022] - CGWL
28th Nov 202210:29 amRNSForm 8.5 (EPT/RI) - Devro PLC
28th Nov 20229:18 amRNSForm 8.5 (EPT/NON-RI)-Devro plc
28th Nov 20229:16 amRNSForm 8.5 (EPT/RI)-Devro plc
25th Nov 20222:48 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re Devro plc
25th Nov 202211:35 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - DEVRO PLC - Ordinary Shares
25th Nov 202210:51 amRNSForm 8.3 - Devro PLC
25th Nov 20229:31 amRNSForm 8.3 - Devro plc
25th Nov 20227:01 amRNSTrading Update
25th Nov 20227:00 amRNSRECOMMENDED CASH ACQUISITION
30th Sep 20222:41 pmRNSBLOCK LISTING SIX MONTHLY RETURN
12th Sep 20224:22 pmRNSHolding(s) in Company
2nd Aug 20227:00 amRNSHalf-year Report
29th Jul 20224:35 pmRNSDirector/PDMR Shareholding
27th Jul 20225:38 pmRNSDirector/PDMR Shareholding
11th May 202212:13 pmRNSDirector/PDMR Shareholding
29th Apr 20223:25 pmRNSTotal Voting Rights and Share Capital
28th Apr 20223:51 pmRNSResult of AGM
28th Apr 20227:00 amRNSAGM Trading Update
14th Apr 20222:22 pmRNSDirector/PDMR Shareholding
13th Apr 20226:10 pmRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSHolding(s) in Company
6th Apr 202212:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.